<DOC>
	<DOCNO>NCT00531479</DOCNO>
	<brief_summary>This study compare effectiveness safety combination anidulafungin voriconazole compare voriconazole alone ( generally consider standard care ) treatment Invasive Aspergillosis .</brief_summary>
	<brief_title>Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Immunocompromised state due either 1. receipt hematopoeitic stem cell transplantation 2. hematologic malignancy ; Diagnosis possible , probable , proven invasive aspergillosis . Patients aspergilloma chronic aspergillosis Receipt 4 day systemic antifungal treatment current episode invasive aspergillosis Anticipated survival le 5 day Karnofsky score &lt; =20</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>